data analytics

Palantir surged 23% in one month on 70% revenue growth and 137% U.S. commercial expansion, but extreme P/E ratio of 255 raises valuation concerns despite solid fundamentals.

Palantir surged nearly 2,000% since ChatGPT's launch, reaching $368B market cap. Despite lofty valuations, AI platform and government contracts justify premium for believers.

Palantir ($PLTR) trades at a 243 P/E ratio yet generated $4.26B in Q4 contract value from 180+ million-dollar deals, justifying premium valuation for growth investors.

Palantir reports $11.2B revenue backlog, $10B Army contract, and 56% YoY growth to $4.5B in 2025, with 61% growth forecast for 2026 despite 241 P/E valuation.

Nvidia faces valuation headwinds despite strong growth. Alphabet and Snowflake offer broader AI exposure with potentially better risk-reward profiles.

Nvidia's 22.4x forward P/E offers better value than Palantir's 114x multiple, despite nearly identical 70%+ growth rates. Nvidia's hardware dominance and AI infrastructure advantage appear more sustainable than Palantir's premium software valuation.

UTime Limited announces $80M nonbinding bid for Feixiaohao to strengthen Web3 infrastructure position, though shares tumble 6.42% amid year-long decline.

$PLTR stock down 24% from November peak; analysts warn of additional 25-50% decline as P/E ratio of 230 far exceeds market norms despite strong 70% revenue growth.

Global big data market projected to reach $1 trillion by 2035 at 13.10% annual growth, driven by AI integration, cloud adoption, and vertical analytics solutions.

Verisk reiterates medium-term targets: 6-8% organic revenue growth, 7-10% EBITDA growth, double-digit EPS expansion. Plans 75% free cash flow returns.

Medidata secures top 'Luminary' AI rating from Everest Group, supporting 80% of FDA approvals with up to 37% faster patient enrollment.

Palantir surged 11% on strong earnings showing 70% revenue growth, but 80x sales valuation leaves little room for error. Analysts recommend waiting for better entry points.

Willis Towers Watson launches a new model to quantify reputational risks from celebrity endorsements, helping companies measure financial impact from endorser controversies.

Palantir trades at elevated 110x forward PE despite strong growth outlook and 43% profit margins. High valuation leaves limited margin for error on execution.